Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.

JW, Moul; H, Wu; L, Sun; DG, McLeod; C, Amling; T, Donahue; L, Kusuda; W, Sexton; K, O'Reilly; J, Hernandez; A, Chung; D, Soderdahl

doi:10.1016/j.juro.2008.03.138

Public

Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.

Shared by NobleBlocks on May 1, 2008 • 12:00 AM UTC

Authors:

Moul JW

Wu H

Sun L

Abstract

Purpose Hormonal therapy (HT) is the current mainstay of systemic treatment for prostate specific antigen (PSA) only recurrence (PSAR), however, there is virtually no published literature comparing HT to observation in the clinical setting. The goal of this study was to examine the Department of Def...

Discussions